Clinical Trial Update: Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]

View source ↗

Summary

This clinical trial update reports the completed results of a Takeda study evaluating Takepron Intravenous 30 mg for acute stress ulcers and acute gastric mucos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Mucosal Lesions
• Stress Ulcer

Drugs mentioned

• Takepron Intravenous 30 mg

Snippet

Sponsor: Takeda | Conditions: Acute Stress Ulcer and Acute Gastric Mucosal Lesions | Status: COMPLETED | Results posted: 2016-03-08